Xtrackers S&P Europe ex UK UCITS ETF 1D | XUEKRegistrer dig for at låse op for ratings |
Fondens performance | 31-03-2024 |
Vækst af 1.000 (DKK) | Avanceret graf |
Fond | 1,6 | 25,3 | -12,9 | 18,3 | 8,7 | |
+/-Kat | -1,6 | 2,4 | 0,8 | 1,8 | 1,0 | |
+/-Indeks | -0,2 | 0,5 | -0,4 | 0,3 | 0,2 | |
Kategori: Aktier - Europa ex. England | ||||||
Kategoribenchmark: Morningstar DM Eur xUK TME ... |
Oversigt | ||
Closing Price 18-04-2024 | EUR 70,16 | |
Kursændring 1 dag | 0,17% | |
Morningstar Kategori™ | Aktier - Europa ex. England | |
Omsætning | 616 | |
Børs | DEUTSCHER KASSENVEREIN AG GRUPPE DEUTSCHE BOERSE | |
ISIN | IE00BGV5VM45 | |
Markedsværdi i alt (mio.) 17-04-2024 | EUR 464,66 | |
Seneste TNA(mio.) 17-04-2024 | EUR 464,66 | |
Løbende omkostning 22-06-2023 | 0,09% | |
Investeringsstrategi | Passiv |
Investeringsmålsætning: Xtrackers S&P Europe ex UK UCITS ETF 1D | XUEK |
The investment objective of the Fund is to track the performance before fees and expenses of the Underlying Asset, which is the S&P Europe Ex-U.K. LargeMidCap (EUR) Index (the "Reference Index"). The Reference Index is designed to reflect the performance of shares of large- and mid-cap constituents of the S&P Europe BMI (the "Parent Index"), excluding the UK. |
Returns | ||||||||||||||||
|
Management | ||
Manager navn Startdato | ||
Ikke oplyst af foreningen 14-01-2019 | ||
Startdato 14-01-2019 |
Annonce |
Kategoribenchmark | |
Fondens indeks | Morningstar indeks |
S&P Europe Ex-U.K. LargeMidCap EUR | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Formuefordeling Xtrackers S&P Europe ex UK UCITS ETF 1D | XUEK | 18-04-2024 |
|
|
Top 5 placeringer | Sektor | % |
Novo Nordisk A/S Class B | Healthcare | 4,94 |
ASML Holding NV | Teknologi | 4,46 |
Nestle SA | Forbrugsvarer | 3,36 |
Lvmh Moet Hennessy Louis Vuitton SE | Cyklisk forbrug | 2,74 |
Novartis AG Registered Shares | Healthcare | 2,37 |
Øget Mindsket Ny siden sidste portefølje | ||
Xtrackers S&P Europe ex UK UCITS ETF 1D | XUEK |